Syntara Limited Director Boosts Stake
Company Announcements

Syntara Limited Director Boosts Stake

Pharmaxis Ltd (AU:SNT) has released an update.

Waradana Malitha Hashan De Silva, a director at Syntara Limited, has significantly increased his indirect interest in the company by acquiring an additional 53,571,429 ordinary shares at $0.028 each, totaling $1,500,000.01, through a placement approved by shareholders. The shares were purchased through AMAL Security Services Pty Ltd, where Mr. De Silva is a managing partner and the transaction took place on September 23, 2024.

For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskSyntara Limited to Present Promising Cancer Trial Results
TipRanks Australian Auto-Generated NewsdeskPharmaxis Ltd Highlights Product Pipeline and Risks
TipRanks Australian Auto-Generated NewsdeskSyntara Limited Advances Drug Trials and Financial Strategy
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App